Poor quality of coal affecting bulk drug production in Telangana?

Is poor quality of coal supplied by Singareni Collieries Company Limited (SCCL) affecting drug production during the pandemic? Raising concerns to this effect, bulk drug manufacturers have written a letter to the state government recently complaining that production was hampered and this had hit their domestic and export commitments.

However, the government-owned coal mining company said every care was taken while supplying coal, adding that the specific coal sought by pharma firms was not available with it due to the prevailing situation.

Bulk Drug Manufacturers’ Association (BDMA) executive director P Eshwar Reddy said the quality of coal that they were being supplied was very poor with 60 per cent shell, stones and dust in it.

Supplies are never ensured as per schedule: Bulk drug body

In the letter to industries minister KT Rama Rao and principal secretary, industries, Jayesh Ranjan, Eshwar said: “Because of this the boilers are not able to generate sufficient steam whenever G7RND coal is used. We have made a representation to the MD of Singareni Collieries and are waiting for their response.”

He said that the firms were working under tight schedules to see that there was no shortage of essential medicines in the country, especially during the pandemic. “Despite several complaints to CGM (marketing), there has been no improvement in quality of coal supplies,” he said.

ET Energy World
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button